CD278

From Wikipedia, the free encyclopedia


Inducible T-cell co-stimulator
Identifiers
Symbol(s) ICOS; AILIM; CD278; MGC39850
External IDs OMIM: 604558 MGI1858745 HomoloGene8097
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 29851 54167
Ensembl ENSG00000163600 ENSMUSG00000026009
Uniprot Q9Y6W8 Q3V3X2
Refseq NM_012092 (mRNA)
NP_036224 (protein)
NM_017480 (mRNA)
NP_059508 (protein)
Location Chr 2: 204.51 - 204.53 Mb Chr 1: 60.92 - 60.94 Mb
Pubmed search [1] [2]

Inducible T-cell co-stimulator, also known as ICOS, is a human gene.[1]

CD278 or ICOS (Inducible T-cell COStimulator) is a CD28-superfamily costimulatory molecule that is expressed on activated T cells. It is thought to be important for Th2 cells in particular.[2][3]

The protein encoded by this gene belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation.[1]

Contents

[edit] ICOS knockout phenotype

Compared to wild-type naïve T cells, ICOS-/- T cells activated with plate-bound anti-CD3 have reduced proliferation and IL-2 secretion(1). The defect in proliferation can be rescued by addition of IL-2 to the culture, suggesting the proliferative defect is due to reduced IL-2 secretion. In terms of Th1 and Th2 cytokine secretion, ICOS-/- CD4+ T cell activated in vitro have reduced IL-4 secretion, but similar IFN-g secretion. Similarly, CD4+ T cells purified from ICOS-/- mice immunized with the protein keyhole limpet hemocyanin (KLH) in alum or Complete Freunds Adjuvant have attenuated IL-4 secretion, but similar IFN-g and IL-5 secretion when recalled with KLH. These data are similar to an airway hypersensitivity model showing similar IL-5 secretion, but reduced IL-4 secretion in response to sensitization with Ova protein, indicating a defect in Th2 cytokine secretion, but not a defect in Th2 differentiation as both IL-4 and IL-5 are Th2-associated cytokines. In agreement with reduced Th2 responses, ICOS-/- mice have reduced germinal center formation and IgG1 and IgE antibody titers in response to immunization.

[edit] References

  1. ^ a b Entrez Gene: ICOS inducible T-cell co-stimulator.
  2. ^ Rudd CE, Schneider H (2003). "Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling". Nat. Rev. Immunol. 3 (7): 544–56. doi:10.1038/nri1131. PMID 12876557. 
  3. ^ Dong C, Juedes AE, Temann UA, Shresta S, Allison JP, Ruddle NH, Flavell RA (2001). "ICOS co-stimulatory receptor is essential for T-cell activation and function". Nature 409 (6816): 97–101. doi:10.1038/35051100. PMID 11343121. 

[edit] Further reading

  • Flesch IE (2003). "Inducible costimulator (ICOS).". J. Biol. Regul. Homeost. Agents 16 (3): 214–6. PMID 12456021. 
  • Shilling RA, Bandukwala HS, Sperling AI (2006). "Regulation of T:B cell interactions by the inducible costimulator molecule: does ICOS "induce" disease?". Clin. Immunol. 121 (1): 13–8. doi:10.1016/j.clim.2006.04.574. PMID 16790364. 
  • Hutloff A, Dittrich AM, Beier KC, et al. (1999). "ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.". Nature 397 (6716): 263–6. doi:10.1038/16717. PMID 9930702. 
  • Yoshinaga SK, Whoriskey JS, Khare SD, et al. (2000). "T-cell co-stimulation through B7RP-1 and ICOS.". Nature 402 (6763): 827–32. doi:10.1038/45582. PMID 10617205. 
  • Ling V, Wu PW, Finnerty HF, et al. (2000). "Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor.". J. Immunol. 164 (4): 1653–7. PMID 10657606. 
  • Aicher A, Hayden-Ledbetter M, Brady WA, et al. (2000). "Characterization of human inducible costimulator ligand expression and function.". J. Immunol. 164 (9): 4689–96. PMID 10779774. 
  • Machado RD, Pauciulo MW, Fretwell N, et al. (2001). "A physical and transcript map based upon refinement of the critical interval for PPH1, a gene for familial primary pulmonary hypertension. The International PPH Consortium.". Genomics 68 (2): 220–8. doi:10.1006/geno.2000.6291. PMID 10964520. 
  • Tezuka K, Tsuji T, Hirano D, et al. (2000). "Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family.". Biochem. Biophys. Res. Commun. 276 (1): 335–45. doi:10.1006/bbrc.2000.3466. PMID 11006126. 
  • Wang S, Zhu G, Chapoval AI, et al. (2000). "Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS.". Blood 96 (8): 2808–13. PMID 11023515. 
  • Breitfeld D, Ohl L, Kremmer E, et al. (2001). "Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production.". J. Exp. Med. 192 (11): 1545–52. PMID 11104797. 
  • Beier KC, Hutloff A, Dittrich AM, et al. (2001). "Induction, binding specificity and function of human ICOS.". Eur. J. Immunol. 30 (12): 3707–17. PMID 11169414. 
  • Ling V, Wu PW, Finnerty HF, et al. (2002). "Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches.". Genomics 78 (3): 155–68. doi:10.1006/geno.2001.6655. PMID 11735222. 
  • Lee YH, Ji JD, Sohn J, Song GG (2002). "Polymorphsims of CTLA-4 exon 1 +49, CTLA-4 promoter -318 and Fas promoter -670 in spondyloarthropathies.". Clin. Rheumatol. 20 (6): 420–2. PMID 11771526. 
  • Haimila KE, Partanen JA, Holopainen PM (2002). "Genetic polymorphism of the human ICOS gene.". Immunogenetics 53 (12): 1028–32. doi:10.1007/s00251-002-0431-2. PMID 11904679. 
  • Wang S, Zhu G, Tamada K, et al. (2002). "Ligand binding sites of inducible costimulator and high avidity mutants with improved function.". J. Exp. Med. 195 (8): 1033–41. PMID 11956294. 
  • Riley JL, Mao M, Kobayashi S, et al. (2002). "Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors.". Proc. Natl. Acad. Sci. U.S.A. 99 (18): 11790–5. doi:10.1073/pnas.162359999. PMID 12195015. 
  • Witsch EJ, Peiser M, Hutloff A, et al. (2002). "ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.". Eur. J. Immunol. 32 (9): 2680–6. doi:10.1002/1521-4141(200209)32:9<2680::AID-IMMU2680>3.0.CO;2-6. PMID 12207353. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Grimbacher B, Hutloff A, Schlesier M, et al. (2003). "Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.". Nat. Immunol. 4 (3): 261–8. doi:10.1038/ni902. PMID 12577056. 

[edit] External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

[edit] References

11111 C. Dong, A. E. Juedes, U. A. Temann et al., Nature 409 (6816), 97 (2001).

Languages